Showing Results for: “diabetes exercise”

The first sub-analysis of renal data from the Dapagliflozin Effect on Cardiovascular Events Thrombolysis In Myocardial Infarction (DECLARE-TIMI 58) trial indicates that dapagliflozin, an oral sodium glucose cotransporter 2 (SGLT2) inhibitor, reduced the progression of kidney disease or renal death in patients with type 2 diabetes (T2D). The initial results from the trial, the first cardiovascular outcome study to enroll a large cohort of patients with diabetes risk factors for Atherosclerotic Cardiovascular Disease (ASCVD) and a large number of patients with diabetes with known ASCVD, were

For 70 years, the American Diabetes Association (ADA) has hosted summer camps for children and teens with type 1 diabetes. In 2019 nearly 7,000 campers, their siblings, and children at-risk of type 2 diabetes, ages 4-17, will attend one of 80 camp sessions nationwide and enjoy a traditional summer camp experience in a medically-safe environment. ADA Camps create opportunities for campers to build life-long friendships, overcome feelings of isolation, and become empowered to manage their diabetes. Additionally, campers participate in physical activity and receive individualized dietary

The American Diabetes Association ® (ADA) welcomes the 2024 principal officers and board of directors. The 15-member board is comprised of forward-thinking and innovative medical, scientific, education, and executive business professionals who will strategically lead and focus efforts to ensure the ADA continues to advance the mission upon which it was founded. "We are so excited to announce our 2024 board of directors,” said Charles “Chuck” Henderson, the ADA’s chief executive officer. “We look forward to the insight and skills each of these thought leaders will provide to help move the

Efforts to advance chronic disease prevention through enhanced education, awareness and support — kicking off during National Kidney Month Today, The American Diabetes Association ® (ADA) and DaVita (NYSE: DVA), a leading provider of kidney care services, announced the expansion of a multi-year collaboration, focused on advancing chronic disease prevention, specifically addressing two of the most prevalent chronic conditions in the U.S. — diabetes and chronic kidney disease (CKD). The kick-off for this expanded effort coincides with National Kidney Month, a time when both organizations bolster

In a submission today to the Senate Finance Committee’s hearing, Bolstering Chronic Care through Medicare Physician Payment, the American Diabetes Association® (ADA) is urging policymakers to boost Medicare payments to physicians and primary care delivery teams to improve care for people with diabetes. A National Policy Roundtable on Diabetes and Primary Care hosted earlier this year by the ADA, and joined by major physician and patient advocacy organizations, made clear that increased reimbursement for all members of a primary care team can both alleviate the health care workforce shortage

Gold Winner for Best Campaign, Health, Non-Profit; Bronze for Best Brand Campaign, Health The American Diabetes Association ® (ADA) announced today that it has been named a Gold Winner for Best Non-Profit Health Campaign and Bronze Winner for Best Brand Campaign in the Health category in the third Annual Anthem Awards. This year’s Anthem Award Winners were selected from a pool of over 2,000 submissions from 44 countries by the International Academy of Digital Arts and Sciences (IADAS). Anthem judges are intellectually diverse leaders from across the impact industry with expertise that spans

Findings Highlight the Impact of Insurance Barriers on Managed Diabetes Care for Diverse Populations Living with Type 1 Diabetes Results from a new study show the impact and importance of continuous glucose monitoring (CGM) that young individuals with diabetes face today. The findings were presented as a Late-Breaking Poster at the 84 th Scientific Sessions of the American Diabetes Association® (ADA) in Orlando, FL. Health disparities is a growing concern that significantly impacts diabetes. In nearly all states, those who identify as Black and Native American are more likely than those who

Project Aims to Remove Barriers to Care to Help Prevent Vision Loss Today, the American Diabetes Association ® (ADA) and Genentech, a member of the Roche Group, announced a new partnership as part of the ADA’s Health Equity Now work to tackle access to screening and treatment for eye diseases that affect the diabetes community. Diabetes is the leading cause of vision loss in people 18–64 years old, and African Americans, American Indians, Alaska Natives, Hispanics/Latinos, and older adults living with diabetes are at higher risk of losing their vision or going blind. 1 Comprehensive eye exams

Today, The American Diabetes Association ® (ADA) announced its recognition as a winner in the 2022 Sharecare Awards in the category of chronic diseases for The Big Step Up: Detection that encourages people to take the big step up for their health. Sharecare (Nasdaq: SHCR ), in association with The National Academy of Television Arts & Sciences, New York Chapter (NY NATAS), the Sharecare Awards promote and reward excellence for the best productions and programming in health and well-being. Each year for Diabetes Awareness Month, the ADA curates a national campaign geared towards motivating

The American Diabetes Association® (ADA), Boys & Girls Club of Snohomish County (BGCSC), and the Cliff Avril Family Foundation have joined up to deliver the ADA’s Project Power for youth to more than 900 area children. The fun, no-cost program for kids ages 5–12 aims to slow the trajectory of childhood obesity and help reduce its consequences, such as type 2 diabetes. Using an outcomes-based curriculum, the program promotes making healthy food choices, increasing physical activity, and building family and peer support. The program will be implemented at several Snohomish County Boys & Girls